GKB Ophthalmics

₹93 1.1 | 1.2%

WEBSITE BSE:533212 NSE : GKB OPHTHA 15 Jan, 14:01

Market Cap ₹47 Cr.

Stock P/E -15.5

P/B 2.3

Current Price ₹93

Book Value ₹ 40.6

Face Value 10

52W High ₹136.4

Dividend Yield 0%

52W Low ₹ 74.1

Edit Ratio

GKB Ophthalmics Research see more...

Overview Inc. Year: 1981Industry: Medical Equipment/Supplies/Accessories

GKB Ophthalmics Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

GKB Ophthalmics Quarterly Results

#(Fig in Cr.)	Dec 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017	Mar 2018
Net Sales	9	10	11	9	8	9
Other Income	0	1	0	0	0	1
Total Income	9	11	11	9	9	10
Total Expenditure	10	11	11	8	9	10
Operating Profit	-1	-1	0	1	-1	-0
Interest	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0
Exceptional Income / Expenses	0	0	0	0	0	0
Profit Before Tax	-1	-1	-1	-0	-1	-1
Provision for Tax	0	-0	0	-0	0	-0
Profit After Tax	-1	-1	-1	0	-2	-1
Adjustments	1	1	1	-0	2	1
Profit After Adjustments	0	0	0	0	0	0
Adjusted Earnings Per Share	-3.4	-2.6	-1.5	0.5	-3.8	-1.3

GKB Ophthalmics Profit & Loss

#(Fig in Cr.)	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Net Sales	31	30	31	38	37	30	26	21	27	28	31	37
Other Income	1	1	2	1	1	3	1	3	2	2	2	1
Total Income	32	31	33	40	38	33	27	25	29	30	33	39
Total Expenditure	26	31	35	39	38	32	26	22	27	29	32	38
Operating Profit	7	0	-1	1	0	2	1	3	2	1	1	0
Interest	3	2	2	1	1	1	1	1	1	1	2	0
Depreciation	1	1	1	1	2	3	3	3	2	3	3	0
Exceptional Income / Expenses	0	1	22	3	0	0	0	-1	0	0	0	0
Profit Before Tax	3	-3	18	1	-3	-3	-4	-2	-2	-3	-3	-3
Provision for Tax	2	-1	4	0	-0	-0	0	-0	0	-0	0	0
Profit After Tax	1	-2	14	1	-3	-3	-4	-2	-2	-3	-3	-4
Adjustments	0	0	0	0	0	0	0	0	0	0	0	4
Profit After Adjustments	1	-2	14	1	-3	-3	-4	-2	-2	-3	-3	0
Adjusted Earnings Per Share	2	-5.4	32.9	1.8	-6.2	-6	-8.3	-4.2	-4.6	-5.7	-6.8	-6.1

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	11%	14%	1%	0%
Operating Profit CAGR	0%	-31%	-13%	-18%
PAT CAGR	0%	0%	0%	NAN%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	-6%	-2%	5%	4%
ROE Average	-13%	-10%	-10%	-1%
ROCE Average	-5%	-4%	-4%	5%

GKB Ophthalmics Balance Sheet

#(Fig in Cr.)	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Shareholder's Funds	18	15	29	30	27	35	35	33	30	28	24
Minority's Interest	0	0	0	0	0	0	0	0	0	0	0
Borrowings	2	0	0	0	0	0	0	1	2	1	1
Other Non-Current Liabilities	1	1	2	2	2	5	5	6	7	7	7
Total Current Liabilities	30	32	17	19	17	19	20	21	19	18	21
Total Liabilities	51	49	48	51	45	59	60	61	58	53	52
Fixed Assets	14	12	12	16	17	24	25	22	21	17	16
Other Non-Current Assets	6	6	6	2	1	9	9	20	22	22	22
Total Current Assets	31	31	30	33	27	25	27	18	14	13	14
Total Assets	51	49	48	51	45	59	60	61	58	53	52

GKB Ophthalmics Cash Flow

#(Fig in Cr.)	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Opening Cash & Cash Equivalents	0	0	0	0	0	0	6	10	1	1	0
Cash Flow from Operating Activities	5	6	-12	-4	-4	5	6	2	2	-1	1
Cash Flow from Investing Activities	-1	0	15	5	2	-9	-6	-12	-1	2	0
Cash Flow from Financing Activities	-5	-6	-3	-1	1	9	3	1	-1	-2	-2
Net Cash Inflow / Outflow	0	0	0	-0	-0	6	4	-9	-0	-1	-0
Closing Cash & Cash Equivalent	0	0	0	0	0	6	10	1	1	0	0

GKB Ophthalmics Ratios

#	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Earnings Per Share (Rs)	2	-5.44	32.89	1.83	-6.2	-5.99	-8.28	-4.18	-4.58	-5.72	-6.78
CEPS(Rs)	4.84	-1.89	36.31	5.05	-2.39	1.41	-1.39	1.75	0.35	-0.68	-1.65
DPS(Rs)	0	0	0	0	0	0	0	0	0	0	0
Book NAV/Share(Rs)	43.32	36.83	69.72	71.24	64.85	68.45	69.93	65.01	60.32	54.59	47.59
Core EBITDA Margin(%)	17.97	-2.48	-10.56	-1.12	-2.63	-3.46	-2.86	-2.69	-1.65	-3.95	-4.09
EBIT Margin(%)	18	-1.71	58.24	5.84	-4.04	-6.11	-11.04	-4.45	-3.6	-5.56	-5.72
Pre Tax Margin(%)	9.13	-9.59	53.36	2.75	-7.32	-10.68	-16.32	-10.72	-8.53	-10.96	-10.83
PAT Margin (%)	2.58	-7.17	41.39	1.87	-6.88	-9.12	-16.32	-9.88	-8.54	-10.39	-10.96
Cash Profit Margin (%)	6.24	-2.48	45.71	5.16	-2.66	2.14	-2.73	4.14	0.66	-1.24	-2.66
ROA(%)	1.62	-4.55	28.39	1.55	-5.36	-5.33	-6.99	-3.48	-3.91	-5.21	-6.51
ROE(%)	4.73	-13.58	61.74	2.6	-9.11	-9.47	-12.45	-6.2	-7.31	-9.95	-13.27
ROCE(%)	18.48	-1.98	63.97	6.51	-4.11	-4.56	-6.27	-2.11	-2.24	-3.81	-4.83
Receivable days	162.94	170.96	123.56	68.43	86.71	127.3	151.28	152.37	90.72	71.59	68.71
Inventory Days	184.55	175.95	162.01	135.03	150.72	129.55	82.01	99.91	83.17	75.04	62.91
Payable days	225.95	283.29	220.28	105.09	96.95	140.1	218.06	269.89	169.94	149.42	135.87
PER(x)	14.55	0	2.01	72.74	0	0	0	0	0	0	0
Price/Book(x)	0.67	1.36	0.95	1.87	1.79	1.35	0.61	1.26	1.53	1.99	1.83
Dividend Yield(%)	0	0	0	0	0	0	0	0	0	0	0
EV/Net Sales(x)	0.77	0.97	1.09	1.61	1.56	1.52	0.84	2.4	2.1	2.36	1.74
EV/Core EBITDA(x)	3.67	67.86	-28.87	61.03	849.47	29.53	32.76	18.54	37.41	65.84	67.67
Net Sales Growth(%)	-2.58	-4.87	4.43	22.92	-3.65	-17.47	-16.1	-16.5	26.73	2.52	12.45
EBIT Growth(%)	271.88	-109.29	3666.92	-87.65	-163.76	-22.91	-51.64	66.3	-2.29	-58.48	-15.67
PAT Growth(%)	169.95	-372.1	704.29	-94.43	-438.35	-7.88	-50.14	49.47	-9.6	-24.72	-18.57
EPS Growth(%)	169.95	-372.1	704.29	-94.43	-438.35	3.44	-38.23	49.47	-9.6	-24.72	-18.57
Debt/Equity(x)	0.69	0.56	0.25	0.24	0.37	0.32	0.28	0.37	0.39	0.41	0.46
Current Ratio(x)	1.04	0.96	1.75	1.69	1.62	1.31	1.32	0.88	0.74	0.76	0.7
Quick Ratio(x)	0.53	0.48	0.92	0.85	0.74	0.96	1.09	0.54	0.46	0.42	0.47
Interest Cover(x)	2.03	-0.22	11.93	1.89	-1.23	-1.34	-2.09	-0.71	-0.73	-1.03	-1.12
Total Debt/Mcap(x)	1.03	0.41	0.26	0.13	0.21	0.23	0.46	0.29	0.25	0.21	0.25

GKB Ophthalmics Shareholding Pattern

#	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoter	59.16	59.09	59.09	59.18	50.86	50.88	50.93	50.95	50.95	50.98
FII	1.98	1.98	1.79	1.79	1.79	1.79	1.79	1.79	1.79	1.79
DII	0	0	0	0	0	0	0	0	0	0
Public	38.86	38.93	39.12	39.03	47.35	47.33	47.28	47.27	47.27	47.23
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoter	0.3	0.3	0.3	0.3	0.26	0.26	0.26	0.26	0.26	0.26
FII	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
DII	0	0	0	0	0	0	0	0	0	0
Public	0.2	0.2	0.2	0.2	0.24	0.24	0.24	0.24	0.24	0.24
Others	0	0	0	0	0	0	0	0	0	0
Total	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5

Pros

Debtor days have improved from 149.42 to 135.87days.
Company is almost debt free.

Cons

Company has a low return on equity of -10% over the last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.